Down syndrome maternal serum screening is largely used in France. The aim of this article is to specify and to explain the different comments applied on the reports in order to optimize the management of the patient. These comments represent the consensus of the study group of the biologist accredited for Down syndrome maternal serum screening.
Keywords: AFP; Dépistage sérique; Maternal serum screening; PAPP-A; Pregnancy management; Suivi de grossesse; Trisomie 21; Trisomy 21; hCG; hCGβ.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.